AYN — Global Testing Cashflow Statement
0.000.00%
- SG$43.69m
- SG$15.81m
- $41.52m
- 98
- 96
- 84
- 100
Annual cashflow statement for Global Testing, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.417 | 7.74 | 12.1 | 3.89 | 5.42 |
| Depreciation | |||||
| Non-Cash Items | -0.442 | -0.015 | -0.229 | -0.659 | -0.722 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.08 | -1.5 | 1.77 | 0.976 | -1.25 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6.56 | 13.5 | 20 | 10.4 | 9.25 |
| Capital Expenditures | -3.25 | -5.51 | -7.84 | -5.4 | -6.73 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.97 | 0.108 | 0 | -9.02 | 6.01 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.28 | -5.41 | -7.84 | -14.4 | -0.715 |
| Financing Cash Flow Items | -0.172 | -0.065 | -0.008 | -2.58 | -1.29 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.18 | -2.06 | -6.05 | -2.78 | -2.23 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.1 | 6.02 | 6.08 | -6.79 | 6.31 |